BioNTech SE Sponsored ADR (BNTX) shares soared 5.8% in the last trading session to close at $105. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

BioNTech’s share price has declined about 57.5% over the past five years, and with the stock closing at US$92.98 and screening as overvalued on market multiples, the key issue is whether the recent ...

Check out the latest Biontech Se (BNTX) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

BioNTech (NASDAQ: BNTX) swung to a Q4 loss and guided for “lower-than-expected” full-year revenue on Tuesday. But the stock crashed more than 20%, mostly because its cofounders, Ugur Sahin (CEO) and ...

BioNTech SE ADR (NASDAQ:BNTX) stock is up 2.8% to trade at $825.41 at last glance, after an Evercore ISI upgrade to "outperform" from "in-line." The analyst in question also hiked its price target to ...

Phase 1/2a trial of BNT324/DB-1311 in solid tumors showed a 32.4% unconfirmed objective response rate and 82.4% disease control rate. BNT324/DB-1311 showed a manageable safety profile across all ...

Below is Validea's guru fundamental report for BIONTECH SE - ADR (BNTX). Of the 22 guru strategies we follow, BNTX rates highest using our Acquirer's Multiple Investor model based on the published ...

Looking ahead to 2030, our model projects BNTX could trade at an average price of $220.30, with a potential range between $165.23 and $275.38. This represents a potential 138.4% return from today's ...